CDT Equity Inc. (CDT) earnings
CDT earnings moved a median of -2.96% by the close. Quarterly and annual CDT reports and results, each read against the price at its own news timestamp. Back to the CDT overview →
14 measured CDT earnings events.
Where these CDT earnings landedvs 14 measured CDT earnings reactions
| Middle 50% of CDT earnings reactions | -10.24% to +0.43% |
|---|---|
| Median reaction (to close) | -2.96% |
| Measured reactions | 14 |
Point-in-time · zero look-ahead
Half of the 14 CDT earnings events with a measured close landed between -10.24% and +0.43%; 29% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q CDT Equity Inc. For: Jun 30 | SEC filing · Form 10-Q | — | +4.49% | |
| Form 10-Q CDT Equity Inc. For: Mar 31 | SEC filing · Form 10-Q | -4.50% | +11.63% | |
| Form NT 10-Q CDT Equity Inc. For: Mar 31 | SEC filing · Form NT | +1.22% | -12.28% | |
| Form 10-K CDT Equity Inc. For: Dec 31 | SEC filing · Form 10-K | -0.25% | -12.62% | |
| Form NT 10-K CDT Equity Inc. For: Dec 31 | SEC filing · Form NT | +1.33% | -4.13% | |
| Form 10-Q CDT Equity Inc. For: Jun 30 | SEC filing · Form 10-Q | -2.32% | -2.38% | |
| Form 10-Q/A CDT Equity Inc. For: Mar 31 | SEC filing · Form 10-Q | -2.32% | -2.38% | |
| Form 10-Q CONDUIT PHARMACEUTICALS For: Mar 31 | SEC filing · Form 10-Q | +2.15% | +4.35% | |
| Form 10-K CONDUIT PHARMACEUTICALS For: Dec 31 | SEC filing · Form 10-K | +0.00% | -21.90% | |
| Form 10-Q CONDUIT PHARMACEUTICALS For: Sep 30 | SEC filing · Form 10-Q | -0.11% | -2.96% | |
| Form 10-Q/A CONDUIT PHARMACEUTICALS For: Jun 30 | SEC filing · Form 10-Q | -0.11% | -2.96% | |
| Form 10-Q/A CONDUIT PHARMACEUTICALS For: Mar 31 | SEC filing · Form 10-Q | -0.11% | -2.96% | |
| Form 10-Q CONDUIT PHARMACEUTICALS For: Jun 30 | SEC filing · Form 10-Q | +1.92% | -19.12% | |
| Form 10-Q CONDUIT PHARMACEUTICALS For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +1.36% |
Keep exploring
More CDT: analyst actions → · SEC filings → · CDT overview →